TY - JOUR AU - Banek, K. AU - Lalani, M. AU - Staedke, S. G. AU - Chandramohan, D. PY - 2014 DA - 2014// TI - Adherence to artemisinin-based combination therapy for the treatment of malaria: a systematic review of the evidence JO - Malar J. VL - 13 UR - https://doi.org/10.1186/1475-2875-13-7 DO - 10.1186/1475-2875-13-7 ID - Banek2014 ER - TY - JOUR AU - Nambozi, M. AU - Kabuya, J. B. AU - Hachizovu, S. AU - Mwakazanga, D. AU - Mulenga, J. AU - Kasongo, W. PY - 2017 DA - 2017// TI - Artemisinin-based combination therapy in pregnant women in Zambia: efficacy, safety and risk of recurrent malaria JO - Malar J. VL - 16 UR - https://doi.org/10.1186/s12936-017-1851-7 DO - 10.1186/s12936-017-1851-7 ID - Nambozi2017 ER - TY - JOUR AU - Warsame, M. AU - Hassan, A. M. AU - Hassan, A. H. AU - Jibril, A. M. AU - Khim, N. AU - Arale, A. M. PY - 2019 DA - 2019// TI - High therapeutic efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Somalia JO - Malar J. VL - 18 UR - https://doi.org/10.1186/s12936-019-2864-1 DO - 10.1186/s12936-019-2864-1 ID - Warsame2019 ER - TY - JOUR AU - Raobela, O. AU - Andriantsoanirina, V. AU - Rajaonera, D. G. AU - Rakotomanga, T. A. AU - Rabearimanana, S. AU - Ralinoro, F. PY - 2018 DA - 2018// TI - Efficacy of artesunate-amodiaquine in the treatment of falciparum uncomplicated malaria in Madagascar JO - Malar J. VL - 17 UR - https://doi.org/10.1186/s12936-018-2440-0 DO - 10.1186/s12936-018-2440-0 ID - Raobela2018 ER - TY - JOUR AU - Naing, C. AU - Whittaker, M. A. AU - Mak, J. W. AU - Aung, K. PY - 2015 DA - 2015// TI - A systematic review of the efficacy of a single dose artemisinin-naphthoquine in treating uncomplicated malaria JO - Malar J. VL - 14 UR - https://doi.org/10.1186/s12936-015-0919-5 DO - 10.1186/s12936-015-0919-5 ID - Naing2015 ER - TY - JOUR AU - Combrinck, J. M. AU - Mabotha, T. E. AU - Ncokazi, K. K. AU - Ambele, M. A. AU - Taylor, D. AU - Smith, P. J. PY - 2013 DA - 2013// TI - Insights into the role of heme in the mechanism of action of antimalarials JO - ACS Chem Biol VL - 8 UR - https://doi.org/10.1021/cb300454t DO - 10.1021/cb300454t ID - Combrinck2013 ER - TY - JOUR AU - Olafson, K. N. AU - Ketchum, M. A. AU - Rimer, J. D. AU - Vekilov, P. G. PY - 2015 DA - 2015// TI - Mechanisms of hematin crystallization and inhibition by the antimalarial drug chloroquine JO - Proc Natl Acad Sci USA VL - 112 UR - https://doi.org/10.1073/pnas.1501023112 DO - 10.1073/pnas.1501023112 ID - Olafson2015 ER - TY - BOOK PY - 2015 DA - 2015// TI - Guidelines for the treatment of malaria PB - World Health Organization CY - Geneva ID - ref8 ER - TY - JOUR AU - Wang, J. Y. AU - Cao, W. C. AU - Shan, C. Q. AU - Zhang, M. AU - Li, G. F. AU - Ding, D. B. PY - 2004 DA - 2004// TI - Naphthoquine phosphate and its combination with artemisinine JO - Acta Trop VL - 89 UR - https://doi.org/10.1016/j.actatropica.2003.11.008 DO - 10.1016/j.actatropica.2003.11.008 ID - Wang2004 ER - TY - JOUR AU - Tun, T. AU - Tint, H. S. AU - Lin, K. AU - Kyaw, T. T. AU - Myint, M. K. AU - Khaing, W. PY - 2009 DA - 2009// TI - Efficacy of oral single dose therapy with artemisinin-naphthoquine phosphate in uncomplicated falciparum malaria JO - Acta Trop VL - 111 UR - https://doi.org/10.1016/j.actatropica.2009.05.007 DO - 10.1016/j.actatropica.2009.05.007 ID - Tun2009 ER - TY - JOUR AU - Wirjanata, G. AU - Sebayang, B. F. AU - Chalfein, F. AU - Prayoga AU - Handayuni, I. AU - Trianty, L. PY - 2015 DA - 2015// TI - Potent ex vivo activity of naphthoquine and methylene blue against drug-resistant clinical isolates of Plasmodium falciparum and Plasmodium vivax JO - Antimicrob Agents Chemother. VL - 59 UR - https://doi.org/10.1128/AAC.00874-15 DO - 10.1128/AAC.00874-15 ID - Wirjanata2015 ER - TY - JOUR AU - Wang, H. AU - Bei, Z. C. AU - Wang, J. Y. AU - Cao, W. C. PY - 2011 DA - 2011// TI - Plasmodium berghei K173: selection of resistance to naphthoquine in a mouse model JO - Exp Parasitol VL - 127 UR - https://doi.org/10.1016/j.exppara.2010.08.020 DO - 10.1016/j.exppara.2010.08.020 ID - Wang2011 ER - TY - JOUR AU - Ariffin, N. M. AU - Islahudin, F. AU - Makmor-Bakry, M. AU - Kumolosasi, E. AU - Hamid, M. H. A. PY - 2017 DA - 2017// TI - Factors affecting primaquine combination treatment in malaria patients in Selangor, Malaysia JO - J Pharm Bioallied Sci. VL - 9 ID - Ariffin2017 ER - TY - JOUR AU - Soldin, O. P. AU - Mattison, D. R. PY - 2009 DA - 2009// TI - Sex differences in pharmacokinetics and pharmacodynamics JO - Clin Pharmacokinet VL - 48 UR - https://doi.org/10.2165/00003088-200948030-00001 DO - 10.2165/00003088-200948030-00001 ID - Soldin2009 ER - TY - JOUR AU - Moore, B. R. AU - Laman, M. AU - Salman, S. AU - Batty, K. T. AU - Page-Sharp, M. AU - Hombhanje, F. PY - 2016 DA - 2016// TI - Naphthoquine: an emerging candidate for artemisinin combination therapy JO - Drugs. VL - 76 UR - https://doi.org/10.1007/s40265-016-0572-5 DO - 10.1007/s40265-016-0572-5 ID - Moore2016 ER - TY - JOUR AU - Qu, H. Y. AU - Gao, H. Z. AU - Hao, G. T. AU - Li, Y. Y. AU - Li, H. Y. AU - Hu, J. C. PY - 2010 DA - 2010// TI - Single-dose safety, pharmacokinetics, and food effects studies of compound naphthoquine phosphate tablets in healthy volunteers JO - J Clin Pharmacol VL - 50 UR - https://doi.org/10.1177/0091270009356296 DO - 10.1177/0091270009356296 ID - Qu2010 ER - TY - JOUR AU - Sun, Y. AU - Wang, S. AU - Ji, J. AU - Zhai, G. AU - Xing, J. PY - 2018 DA - 2018// TI - Metabolite identification of the antimalarial naphthoquine using liquid chromatography-tandem high-resolution mass spectrometry in combination with multiple data-mining tools JO - Biomed Chromatogr VL - 32 UR - https://doi.org/10.1002/bmc.4207 DO - 10.1002/bmc.4207 ID - Sun2018 ER - TY - JOUR AU - Roederer, M. W. AU - McLeod, H. AU - Juliano, J. J. PY - 2011 DA - 2011// TI - Can pharmacogenomics improve malaria drug policy? JO - Bull World Health Organ VL - 89 UR - https://doi.org/10.2471/BLT.11.087320 DO - 10.2471/BLT.11.087320 ID - Roederer2011 ER - TY - JOUR AU - Gordi, T. AU - Huong, D. X. AU - Hai, T. N. AU - Nieu, N. T. AU - Ashton, M. PY - 2002 DA - 2002// TI - Artemisinin pharmacokinetics and efficacy in uncomplicated-malaria patients treated with two different dosage regimens JO - Antimicrob Agents Chemother VL - 46 UR - https://doi.org/10.1128/AAC.46.4.1026-1031.2002 DO - 10.1128/AAC.46.4.1026-1031.2002 ID - Gordi2002 ER - TY - JOUR AU - Kamya, M. R. AU - Gasasira, A. F. AU - Yeka, A. AU - Bakyaita, N. AU - Nsobya, S. L. AU - Francis, D. PY - 2006 DA - 2006// TI - Effect of HIV-1 infection on antimalarial treatment outcomes in Uganda: a population-based study JO - J Infect Dis VL - 193 UR - https://doi.org/10.1086/498577 DO - 10.1086/498577 ID - Kamya2006 ER - TY - JOUR AU - Batty, K. T. AU - Salman, S. AU - Moore, B. R. AU - Benjamin, J. AU - Lee, S. T. AU - Page-Sharp, M. PY - 2012 DA - 2012// TI - Artemisinin-naphthoquine combination therapy for uncomplicated pediatric malaria: a pharmacokinetic study JO - Antimicrob Agents Chemother VL - 56 UR - https://doi.org/10.1128/AAC.06250-11 DO - 10.1128/AAC.06250-11 ID - Batty2012 ER - TY - JOUR AU - Meibohm, B. AU - Beierle, I. AU - Derendorf, H. PY - 2002 DA - 2002// TI - How important are gender differences in pharmacokinetics? JO - Clin Pharmacokinet VL - 41 UR - https://doi.org/10.2165/00003088-200241050-00002 DO - 10.2165/00003088-200241050-00002 ID - Meibohm2002 ER - TY - JOUR AU - Gandhi, M. AU - Aweeka, F. AU - Greenblatt, R. M. AU - Blaschke, T. F. PY - 2004 DA - 2004// TI - Sex differences in pharmacokinetics and pharmacodynamics JO - Annu Rev Pharmacol Toxicol VL - 44 UR - https://doi.org/10.1146/annurev.pharmtox.44.101802.121453 DO - 10.1146/annurev.pharmtox.44.101802.121453 ID - Gandhi2004 ER - TY - JOUR AU - Soldin, O. P. AU - Chung, S. H. AU - Mattison, D. R. PY - 2011 DA - 2011// TI - Sex differences in drug disposition JO - J Biomed Biotechnol. VL - 2011 UR - https://doi.org/10.1155/2011/187103 DO - 10.1155/2011/187103 ID - Soldin2011 ER - TY - JOUR AU - Beierle, I. AU - Meibohm, B. AU - Derendorf, H. PY - 1999 DA - 1999// TI - Gender differences in pharmacokinetics and pharmacodynamics JO - Int J Clin Pharmacol Ther VL - 37 ID - Beierle1999 ER - TY - JOUR AU - Simpson, J. A. AU - Agbenyega, T. AU - Barnes, K. I. AU - Perri, G. AU - Folb, P. AU - Gomes, M. PY - 2006 DA - 2006// TI - Population pharmacokinetics of artesunate and dihydroartemisinin following intra-rectal dosing of artesunate in malaria patients JO - PLoS Med. VL - 3 UR - https://doi.org/10.1371/journal.pmed.0030444 DO - 10.1371/journal.pmed.0030444 ID - Simpson2006 ER - TY - JOUR AU - Binh, V. Q. AU - Chinh, N. T. AU - Thanh, N. X. AU - Cuong, B. T. AU - Quang, N. N. AU - Dai, B. PY - 2009 DA - 2009// TI - Sex affects the steady-state pharmacokinetics of primaquine but not doxycycline in healthy subjects JO - Am J Trop Med Hyg VL - 81 UR - https://doi.org/10.4269/ajtmh.2009.09-0214 DO - 10.4269/ajtmh.2009.09-0214 ID - Binh2009 ER - TY - JOUR AU - Tansley, R. AU - Lotharius, J. AU - Priestley, A. AU - Bull, F. AU - Duparc, S. AU - Mohrle, J. PY - 2010 DA - 2010// TI - A randomized, double-blind, placebo-controlled study to investigate the safety, tolerability, and pharmacokinetics of single enantiomer (+)-mefloquine compared with racemic mefloquine in healthy persons JO - Am J Trop Med Hyg VL - 83 UR - https://doi.org/10.4269/ajtmh.2010.10-0228 DO - 10.4269/ajtmh.2010.10-0228 ID - Tansley2010 ER - TY - JOUR AU - Wernsdorfer, W. H. AU - Noedl, H. AU - Rendi-Wagner, P. AU - Kollaritsch, H. AU - Wiedermann, G. AU - Mikolasek, A. PY - 2013 DA - 2013// TI - Gender-specific distribution of mefloquine in the blood following the administration of therapeutic doses JO - Malar J. VL - 12 UR - https://doi.org/10.1186/1475-2875-12-443 DO - 10.1186/1475-2875-12-443 ID - Wernsdorfer2013 ER - TY - JOUR AU - Martignoni, M. AU - Groothuis, G. M. M. AU - Kanter, R. PY - 2006 DA - 2006// TI - Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction JO - Expert Opin Drug Metab Toxicol. VL - 2 UR - https://doi.org/10.1517/17425255.2.6.875 DO - 10.1517/17425255.2.6.875 ID - Martignoni2006 ER - TY - JOUR AU - Hiroi, T. AU - Chow, T. AU - Imaoka, S. AU - Funae, Y. PY - 2002 DA - 2002// TI - Catalytic specificity of CYP2D isoforms in rat and human JO - Drug Metab Dispos VL - 30 UR - https://doi.org/10.1124/dmd.30.9.970 DO - 10.1124/dmd.30.9.970 ID - Hiroi2002 ER - TY - JOUR AU - Kishino, S. AU - Nomura, A. AU - Di, Z. S. AU - Sugawara, M. AU - Iseki, K. AU - Kakinoki, S. PY - 1995 DA - 1995// TI - Alpha-1-acid glycoprotein concentration and the protein binding of disopyramide in healthy subjects JO - J Clin Pharmacol VL - 35 UR - https://doi.org/10.1002/j.1552-4604.1995.tb04096.x DO - 10.1002/j.1552-4604.1995.tb04096.x ID - Kishino1995 ER - TY - JOUR AU - Harris, R. Z. AU - Benet, L. Z. AU - Schwartz, J. B. PY - 1995 DA - 1995// TI - Gender effects in pharmacokinetics and pharmacodynamics JO - Drugs. VL - 50 UR - https://doi.org/10.2165/00003495-199550020-00003 DO - 10.2165/00003495-199550020-00003 ID - Harris1995 ER - TY - JOUR AU - Yang, S. H. AU - Yang, K. H. AU - Lee, M. G. PY - 2008 DA - 2008// TI - Gender differences in ondansetron pharmacokinetics in rats JO - Biopharm Drug Dispos VL - 29 UR - https://doi.org/10.1002/bdd.627 DO - 10.1002/bdd.627 ID - Yang2008 ER -